Loading...
Loading...

Programs

PHE 09 Header
The growth in the monoclonal and recombinant antibodies area has been made possible by methods to create peptide libraries by phage display and engineer properties to enable them to become protein therapeutics. The improvements in speed and throughput along with advances in manipulating properties such as multi-specificity, immunogenicity, and aggregation will lead to the next generation of therapeutic antibodies for the clinic. Find out how phage display is pivotal to this growth area, and what new technologies will be creating the next wave of biologics.  go to conference page 

PXEA 09 Header
Great strides have been made in the expression of proteins for structure and characterization studies, as well as for therapeutics and diagnostics. However, with these strides have come new obstacles. Higher throughput expression and purification, as well as more flexible expression systems and techniques are now in even greater demand to support the needs of the research pipeline. It has become even more important to prevent problems in protein expression by wise choices in data analysis well before the task goes into the laboratory. This conference will explore the newest data and innovations relating to the expression and characterization of proteins for biological understanding and therapeutics, as well as strategies to make the eventual expression of these proteins more effective, efficient and trouble-free.  go to conference page 

RBE 09 Header
Although therapeutic antibodies have come a long way in the past several years, many problems still exist in the production and use of these complex molecules. The negative qualities of these proteins, including immunogenicity, delivery difficulties, and the high cost of production, among others, have made the outcomes of their production and use less than satisfactory. In order to improve or eliminate these negatives, it is critical to find new ways to engineer antibodies, new antibody alternatives (such as mimetics, fragments, etc.) and novel ways to scale up production to provide large amounts of these proteins in a cost-effective way. This conference will present the latest data on how to achieve these improved results and the research data necessary to apply the solutions to your laboratory’s efforts.  go to conference page 

PXEB 09 Header
Many of the original workhorse technologies and methodologies continue to be in the forefront of Protein Expression. However, new technologies are emerging that hold the promise of improving yields, simplifying isolation and characterization and advancing the capabilities of protein engineering for the next century. This conference will present the new technologies and methodologies, as well as cutting-edge applications of this break-through science.  go to conference page 


 
Loading...

Japanese Simple Chinese Traditional Chinese Korean 

Register by

Download 2010
Final Brochure


Premier Sponsor:

VTU Technology GmbH

Corporate Sponsors:

BioSilta

CEVEC

Enzo Life Sciences Assay Designs

Forte Bio

GTP

Precision Antibody

Corporate Support
Sponsors:

Crucell

Malvern

MedImmune


Held in Conjunction with: 

Biotechnica
Europe's No.1 Event
in Biotechnology and
Life Sciences 

about Biotechnica


Sponsoring Organizations:

eapb logo

Finnish Bioindistries

Hungarian Biotechnology Association

VBIO

LISA


Media Partners:

Association for Clinical Data Management

 Nature_logo

Science AAAS logo

Additional Media Partners 

 

 

 

Loading...

Cambridge Healthtech Institute  |  250 First Avenue, Suite 300  |  Needham MA 02494  |   phone: 781-972-5400  |   fax: 781-972-5425 chi@healthtech.com